| Literature DB >> 28188150 |
Christian Eckhoff1,2, Bjørn Straume3, Siv Kvernmo1,2.
Abstract
OBJECTIVES: To examine the association between multisite musculoskeletal pain in adolescence and mental health disorders in young adulthood. DESIGN ANDEntities:
Keywords: EPIDEMIOLOGY; MENTAL HEALTH; PSYCHIATRY; PUBLIC HEALTH
Mesh:
Year: 2017 PMID: 28188150 PMCID: PMC5306523 DOI: 10.1136/bmjopen-2016-012035
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
The association between adolescent musculoskeletal pain and mental healthcare use* in young adulthood, adjusted for adolescent sociodemographic, physical and psychosocial factors (Final model: n=3302)
| Mental healthcare use in young adulthood | ||
|---|---|---|
| Adolescent factors | n | OR (95% CI)/R2 |
| Step 1: | ||
| 3583 | R2=0.026 | |
| Female gender | 1.47 (1.21 to 1.79)p<0.001 | |
| Sami | 0.86 (0.61 to 1.20)p=0.372 | |
| Higher parental education | 0.89 (0.78 to 1.00)p=0.051 | |
| Family income | 0.68 (0.59 to 0.78)p<0.001 | |
| 3602 | R2=0.041 | |
| Musculoskeletal pain | 1.27 (1.18 to 1.37)p<0.001 | |
| Sedentary activity | 0.99 (0.89 to 1.11)p=0.909 | |
| Physical activity | 0.72 (0.64 to 0.80)p<0.001 | |
| | ||
| 3790 | R2=0.037 | |
| Self-efficacy | 0.91 (0.88 to 0.94)p<0.001 | |
| Parental involvement | 1.02 (0.98 to 1.07)p=0.320 | |
| Parental support | 1.07 (1.04 to 1.11)p<0.001 | |
| Peer support | 1.05 (0.99 to 1.09)p=0.053 | |
| 3703 | R2=0.046 | |
| School-related stress | 1.18 (1.12 to 1.24)p<0.001 | |
| Adverse life events | 1.14 (1.08 to 1.20)p<0.001 | |
| 3876 | R2=0.060 | |
| Anxiety/depression | 2.51 (2.15 to 2.93)p<0.001 | |
| Step 2: | ||
| 3572 | R2=0.058 | |
| Female gender | 1.25 (1.02 to 1.53)p=0.036 | |
| Family income | 0.68 (0.59 to 0.79)p<0.001 | |
| Musculoskeletal pain | 1.24 (1.15 to 1.34)p<0.001 | |
| Physical activity | 0.75 (0.67 to 0.84)p<0.001 | |
| 3578 | R2=0.066 | |
| Self-efficacy | 0.96 (0.92 to 0.99)p=0.026 | |
| Parental support | 1.02 (0.99 to 1.06)p=0.182 | |
| School-related stress | 1.10 (1.04 to 1.17)p=0.001 | |
| Adverse life events | 1.07 (1.01 to 1.13)p=0.029 | |
| Anxiety/depression | 1.64 (1.33 to 2.02)p<0.001 | |
| Step 3/final model† (model 6+7): | 3302 | R2=0.081 |
| Female gender | 1.01 (0.80 to 1.27)p=0.965 | |
| Family income | 0.76 (0.65 to 0.90)p=0.001 | |
| Musculoskeletal pain | 1.05 (0.96 to 1.15)p=0.329 | |
| Physical activity | 0.79 (0.69 to 0.89)p<0.001 | |
| Self-efficacy | 0.98 (0.94 to 1.02)p=0.326 | |
| School-related stress | 1.07 (1.01 to 1.14)p=0.024 | |
| Adverse life events | 1.06 (0.99 to 1.13)p=0.055 | |
| Anxiety/depression | 1.63 (1.29 to 2.07)p<0.001 | |
Statistical analyses: hierarchical logistic regression.
*Patient data from the Norwegian Patient Registry.
†Bonferroni adjusted significance level 0.0063 for the final model.
The association between adolescent musculoskeletal pain and mental health disorders* in young adulthood, adjusted for adolescent sociodemographic, physical and psychosocial factors (Final model: n=3464)
| Mood | Anxiety | Developmental and behavioural | Undiagnosed n=129 | ||
|---|---|---|---|---|---|
| Adolescent factors | n | OR (95% CI)/R2 | |||
| Step 1: | |||||
| 3918 | R2=0.032 | R2=0.034 | R2=0.024 | R2=0.002 | |
| Female gender | 1.88 (1.35 to 2.61)p<0.001 | 2.04 (1.50 to 2.77)p<0.001 | 1.74 (1.20 to 2.53)p=0.003 | 1.12 (0.78 to 1.60)p=0.546 | |
| Family income | 0.60 (0.47 to 0.75)p<0.001 | 0.63 (0.51 to 0.78)p<0.001 | 0.62 (0.48 to 0.80)p<0.001 | 0.84 (0.64 to 1.09)p=0.190 | |
| 3618 | R2=0.062 | R2=0.043 | R2=0.022 | R2=0.008 | |
| Musculoskeletal pain | 1.36 (1.20 to 1.54)p<0.001 | 1.43 (1.28 to 1.61)p<0.001 | 1.29 (1.12 to 1.49)p<0.001 | 1.14 (0.98 to 1.31)p=0.084 | |
| Physical activity | 0.54 (0.44 to 0.67)p<0.001 | 0.75 (0.63 to 0.90)p=0.001 | 0.78 (0.63 to 0.97)p=0.022 | 0.81 (0.65 to 1.00)p=0.051 | |
| 3892 | R2=0.016 | R2=0.029 | R2=0.024 | R2=0.003 | |
| Self-efficacy | 0.88 (0.83 to 0.93)p<0.001 | 0.85 (0.81 to 0.89)p<0.001 | 0.85 (0.80 to 0.91)p<0.001 | 0.95 (0.89 to 1.01)p=0.111 | |
| 3703 | R2=0.033 | R2=0.032 | R2=0.025 | R2=0.025 | |
| School-related stress | 1.24 (1.14 to 1.35)p<0.001 | 1.22 (1.13 to 1.31)p<0.001 | 1.18 (1.07 to 1.31)p=0.001 | 1.14 (1.04 to 1.25)p=0.008 | |
| Adverse life events | 1.07 (0.97 to 1.17)p=0.169 | 1.08 (0.99 to 1.17)p=0.066 | 1.11 (1.00 to 1.23)p=0.044 | 1.15 (1.04 to 1.27)p=0.005 | |
| 3876 | R2=0.050 | R2=0.062 | R2=0.033 | R2=0.010 | |
| Anxiety/depression | 2.62 (2.07 to 3.31)p<0.001 | 2.81 (2.28 to 3.48)p<0.001 | 2.27 (1.75 to 2.95)p<0.001 | 1.64 (1.23 to 2.20)p=0.001 | |
| Step 2: | |||||
| 3572 | R2=0.082 | R2=0.058 | R2=0.038 | R2=0.011 | |
| Female gender | 1.63 (1.13 to 2.36)p=0.009 | 1.51 (1.09 to 2.11)p=0.015 | 1.66 (1.10 to 2.15)p=0.015 | 1.01 (0.68 to 1.51)p=0.954 | |
| Family income | 0.64 (0.50 to 0.82)p<0.001 | 0.68 (0.54 to 0.85)p=0.001 | 0.63 (0.48 to 0.83)p=0.001 | 0.83 (0.62 to 1.10)p=0.198 | |
| Musculoskeletal pain | 1.29 (1.14 to 1.47)p<0.001 | 1.36 (1.21 to 1.53)p<0.001 | 1.19 (1.03 to 1.38)p=0.018 | 1.12 (0.97 to 1.30)p=0.135 | |
| Physical activity | 0.58 (0.47 to 0.72)p<0.001 | 0.80 (0.67 to 0.96)p=0.016 | 0.86 (0.69 to 1.07)p=0.184 | 0.81 (0.65 to 1.02)p=0.068 | |
| 3803 | R2=0.061 | R2=0.071 | R2=0.046 | R2=0.025 | |
| Self-efficacy | 0.96 (0.90 to 1.02)p=0.175 | 0.92 (0.87 to 0.97)p=0.003 | 0.88 (0.82 to 0.95)p=0.001 | – | |
| School-related stress | 1.16 (1.06 to 1.27)p=0.001 | 1.13 (1.04 to 1.22)p=0.005 | 1.09 (0.98 to 1.22)p=0.121 | 1.12 (1.01 to 1.25)p=0.030 | |
| Adverse life events | – | – | 1.05 (0.94 to 1.18)p=0.370 | 1.13 (1.02 to 1.26)p=0.018 | |
| Anxiety/depression | 1.95 (1.46 to 2.60)p<0.001 | 2.00 (1.54 to 2.60)p<0.001 | 1.47 (1.00 to 2.15)p=0.049 | 1.15 (0.79 to 1.69)p=0.464 | |
| Step3/final model† (model 6+7): | 3464 | R2=0.100 | R2=0.079 | R2=0.054 | R2=0.030 |
| Female gender | 1.39 (0.93 to 2.07)p=0.109 | 1.23 (0.86 to 1.75)p=0.267 | 1.35 (0.87 to 2.10)p=0.179 | 0.97 (0.64 to 1.47)p=0.892 | |
| Family income | 0.68 (0.53 to 0.87)p=0.002 | 0.74 (0.59 to 0.94)p=0.012 | 0.72 (0.54 to 0.96)p=0.025 | 0.86 (0.64 to 1.16)p=0.333 | |
| Musculoskeletal pain | 1.13 (0.98 to 1.31)p=0.102 | 1.21 (1.06 to 1.38)p=0.006 | 1.06 (0.91 to 1.25)p=0.450 | 0.98 (0.83 to 1.16)p=0.811 | |
| Physical activity | 0.62 (0.49 to 0.77)p<0.001 | 0.86 (0.72 to 1.04)p=0.112 | 0.93 (0.74 to 1.17)p=0.535 | 0.84 (0.67 to 1.05)p=0.131 | |
| Self-efficacy | – | 0.95 (0.89 to 1.01)p=0.077 | 0.92 (0.85 to 0.99)p=0.026 | – | |
| School-related stress | 1.08 (0.98 to 1.20)p=0.138 | 1.04 (0.95 to 1.14)p=0.380 | – | 1.15 (1.04 to 1.28)p=0.010 | |
| Adverse life events | – | – | – | 1.13 (1.01 to 1.26)p=0.036 | |
| Anxiety/depression | 1.69 (1.20 to 2.37)p=0.002 | 1.70 (1.24 to 2.34)p=0.001 | 1.68 (1.17 to 2.39)p=0.005 | – | |
Statistical analyses: hierarchical logistic regression.
*Patient data from the Norwegian Patient Registry.
†Bonferroni adjusted significance level 0.0083 for the final model of mood, developmental and behavioural disorder, and 0.0071 for anxiety disorders.
The number of adolescent musculoskeletal pain sites, by gender and the association with mental healthcare use*, mental healthcare treatment and mental health disorders in young adulthood
| Number of adolescent musculoskeletal pain sites | |||||||
|---|---|---|---|---|---|---|---|
| Factors (n/%/mean) | n | 0 | 1 | 2 | 3 | 4 | χ2/F-ratio |
| 121.42p<0.001 | |||||||
| Females (n (%)) | 1843 | n=395 (21.4) | n=494 (26.8) | n=433 (23.5) | n=314 (17.0) | n=207 (11.2) | |
| Males (n (%)) | 1877 | n=638 (34.0) | n=576 (30.7) | n=359 (19.1) | n=181 (9.6) | n=123 (6.6) | |
| Females | 1843 | 11.1 | 11.3 | 17.3 | 19.7 | 24.2 | 27.28p<0.001 |
| Males | 1877 | 9.2 | 9.5 | 9.2 | 18.8 | 17.9 | 13.32p<0.001 |
| Total outpatient hours (M) | 3720 | 2.84 | 2.23 | 4.03 | 4.69 | 8.66 | 3.19p=0.013 |
| Inpatients (%) | 3720 | 2.0 | 2.8 | 2.8 | 4.0 | 7.3 | 18.71p<0.001 |
| Total inpatient days (M) | 3720 | 3.08 | 3.11 | 1.36 | 3.71 | 5.97 | 1.36p=0.247 |
| Substance use | 3720 | 1.3 | 1.4 | 1.3 | 1.8 | 3.3 | 4.77p=0.029 |
| Psychotic | 3720 | 0.7 | 0.7 | 0.4 | 0.8 | 0.9 | 0.43p=0.835 |
| Mood | 3720 | 2.5 | 2.7 | 4.8 | 6.5 | 7.9 | 29.96p<0.001 |
| Females | 1843 | 3.3 | 2.8 | 7.2 | 8.0 | 8.7 | 16.77p<0.001 |
| Males | 1877 | 2.0 | 2.6 | 1.9 | 3.9 | 6.5 | 5.65p=0.017 |
| Anxiety | 3720 | 2.6 | 3.6 | 5.3 | 8.3 | 10.0 | 44.95p<0.001 |
| Females | 1843 | 3.3 | 4.5 | 7.2 | 8.3 | 11.6 | 20.68p<0.001 |
| Males | 1877 | 2.2 | 2.8 | 3.1 | 8.3 | 7.3 | 16.17p<0.001 |
| Developmental and behavioural | 3720 | 3.0 | 1.9 | 3.0 | 4.6 | 6.7 | 12.85p<0.001 |
| Females | 1843 | 3.8 | 2.4 | 3.7 | 5.7 | 7.2 | 6.94p=0.008 |
| Males | 1877 | 2.5 | 1.4 | 2.2 | 2.8 | 5.7 | 2.47p=0.116 |
| Undiagnosed | 3720 | 2.8 | 2.5 | 2.7 | 4.8 | 3.6 | 3.06p=0.080 |
| Females | 1843 | 2.3 | 2.6 | 3.2 | 4.8 | 4.3 | 4.21p=0.040 |
| Males | 1877 | 3.1 | 2.4 | 1.9 | 5.0 | 2.4 | 0.02p=0.886 |
| Yes: | 679 | ||||||
| Mental healthcare users | 156 | 17.6 | 16.4 | 20.7 | 25.3 | 30.3 | 8.84p=0.003 |
| Inpatients | 37 | 2.7 | 4.5 | 5.2 | 5.4 | 7.7 | 2.54p=0.111 |
| No: | 2967 | ||||||
| Mental healthcare users | 325 | 9.6 | 9.6 | 11.4 | 16.1 | 14.6 | 11.06p=0.001 |
| Inpatients | 78 | 2.0 | 2.5 | 2.1 | 3.4 | 6.7 | 7.36p=0.007 |
| Yes: | 1059 | ||||||
| Mental healthcare users | 178 | 0 | 11.2 | 15.9 | 18.8 | 25.4 | 12.78p<0.001 |
| Inpatients | 36 | 0 | 1.6 | 3.5 | 3.2 | 6.5 | 4.04p=0.044 |
| No: | 1650 | ||||||
| Mental healthcare users | 200 | 7.2 | 10.3 | 12.4 | 20.1 | 14.6 | 15.08p<0.001 |
| Inpatients | 55 | 1.4 | 3.3 | 2.6 | 4.5 | 7.3 | 6.55p=0.010 |
Statistical analyses: χ2 analysis (linear-by-linear association) and one-way ANOVA test for trend. Stratified analyses on gender, adolescent anxiety/depression symptoms and adolescent pain-related functional impairment.
*Patient data from the Norwegian Patient Registry.
ANOVA, analysis of variance
Adult mental healthcare use, mental health disorders and treatment in a cohort of adolescents, registry-based data*
| Factors (%/mean) | Females | Males | Total | χ2/F-ratio |
|---|---|---|---|---|
| Total sample (%): | n=1991 | n=1996 | n=3987 | |
| Mental healthcare users | 16.2 | 11.0 | 13.6 | 22.48p<0.001 |
| Inpatient | 3.0 | 3.4 | 3.2 | 0.28p=0.598 |
| Substance use | 0.9 | 2.3 | 1.6 | 11.51p=0.001 |
| Psychotic | 0.7 | 0.8 | 0.7 | 0.03p=0.855 |
| Mood | 5.5 | 2.8 | 4.1 | 17.23p<0.001 |
| Anxiety | 6.7 | 3.4 | 5.0 | 23.00p<0.001 |
| Developmental and behavioural | 4.2 | 2.4 | 3.3 | 9.83p=0.002 |
| Undiagnosed | 3.5 | 3.0 | 3.2 | 0.53p=0.465 |
| Mental healthcare users (%/mean): | n=323 | n=220 | n=543 | |
| Public mental healthcare (%) | 93.8 | 95.5 | 94.5 | 0.40p=0.527 |
| Private specialist (%) | 16.7 | 9.5 | 13.8 | 5.07p=0.024 |
| Inpatient (%) | 18.6 | 30.5 | 23.4 | 9.65p=0.002 |
| Total outpatient contacts (M) | 27.54 (60.83) | 22.03 (54.56) | 25.31 (58.38) | 1.17p=0.281 |
| Total outpatient hours (M) | 31.53 (83.79) | 21.31 (63.59) | 27.39 (76.35) | 2.35p=0.126 |
| Total inpatient admissions (M) | 0.61 (2.25) | 0.74 (1.59) | 0.66 (2.01) | 0.54p=0.461 |
| Total inpatient days (M) | 17.00 (70.36) | 32.82 (100.98) | 23.41 (84.39) | 4.63p=0.032 |
Statistical analyses: χ2 analysis and one-way ANOVA.
*Patient data from the Norwegian Patient Registry.
ANOVA, analysis of variance.
Figure 1χ2 Test for trend. The relationship between the number of adolescent musculoskeletal pain sites and (A) mental healthcare users and (B) mental health disorders (data in table 2).